Saldaña-Téllez, Minerva
Meneses-Navarro, Sergio
Cano-Garduño, Leonor
Unger-Saldaña, Karla
Article History
Received: 8 March 2023
Accepted: 29 December 2023
First Online: 13 January 2024
Declarations
:
: The study received approval from the National Cancer Institute of Mexico’s institutional review boards (021/041/IBI) (CEI/1592/21). All methods have been performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.
: The possibility of publication of de-identified data was explained to the participants in the written informed consent forms.
: The authors declare no competing interests.